What kind of interaction is it?

Caution: an interaction that may reduce efficacy or raise side-effect risk and warrants monitoring.

Is this interaction backed by published research?

Yes. NutriStack lists 2 citation rows for the Methylprednisolone + Schisandra pair, each linking to PubMed by PMID where available. Full sourcing methodology at https://nutristackapp.com/methodology/interactions.

Interaction databaseSupplement × PrescriptionReviewed May 2026

Methylprednisolone and Schisandra, a caution.

Q: Can I take Methylprednisolone and Schisandra together?

Possibly, but with caution. Methylprednisolone and Schisandra have a documented caution-tier interaction. Schisandra extract has human evidence of inhibiting CYP3A activity, and methylprednisolone exposure is highly sensitive to CYP3A inhibition. Combining them could raise steroid exposure and increase systemic adverse effects such as mood changes, high glucose, fluid retention, and adrenal suppression.

Q: How does this affect a NutriStack Stack Score?

-5 to your Stack Score per scored caution row.

Schisandra extract has human evidence of inhibiting CYP3A activity, and methylprednisolone exposure is highly sensitive to CYP3A inhibition. Combining them could raise steroid exposure and increase systemic adverse effects such as mood changes, high glucose, fluid retention, and adrenal suppression.

2 primary source citations. Moderate evidence. Last verified May 30, 2026.

Open the interaction checker →Read the methodology

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances: Methylprednisolone and Schisandra
Pair type: Caution
Evidence (highest tier): Moderate
Source citations: 2 sources
Stack Score effect: −5 to your Stack Score (per scored caution row).
Scope: Supplement × Prescription
Last verified: May 30, 2026

Caution · Moderate evidence

Caution

What is happening. Schisandra extract has human evidence of inhibiting CYP3A activity, and methylprednisolone exposure is highly sensitive to CYP3A inhibition. Combining them could raise steroid exposure and increase systemic adverse effects such as mood changes, high glucose, fluid retention, and adrenal suppression.

Mechanism. Schisandra lignans can inhibit CYP3A, increasing exposure to CYP3A probe substrates in humans. Methylprednisolone is metabolized by CYP3A4, and potent CYP3A inhibitors markedly increase methylprednisolone AUC and cortisol suppression.

Recommendation. Avoid starting high-dose Schisandra during methylprednisolone therapy unless your prescriber knows. If the combination is used, monitor for stronger steroid effects and do not abruptly stop methylprednisolone after prolonged use.

Sources (2)

Stack Score

How this pair moves the number.

Effect on the composite score

If both Methylprednisolone and Schisandra are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

Open the interaction checker →Browse the full research index